ZA741420B - Hypolipidemic agents - Google Patents

Hypolipidemic agents

Info

Publication number
ZA741420B
ZA741420B ZA00741420A ZA741420A ZA741420B ZA 741420 B ZA741420 B ZA 741420B ZA 00741420 A ZA00741420 A ZA 00741420A ZA 741420 A ZA741420 A ZA 741420A ZA 741420 B ZA741420 B ZA 741420B
Authority
ZA
South Africa
Prior art keywords
hypolipidemic agents
hypolipidemic
agents
Prior art date
Application number
ZA00741420A
Other languages
English (en)
Inventor
R Parker
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of ZA741420B publication Critical patent/ZA741420B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00741420A 1973-04-02 1974-03-05 Hypolipidemic agents ZA741420B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/347,064 US4110351A (en) 1973-04-02 1973-04-02 Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts

Publications (1)

Publication Number Publication Date
ZA741420B true ZA741420B (en) 1975-01-29

Family

ID=23362171

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00741420A ZA741420B (en) 1973-04-02 1974-03-05 Hypolipidemic agents

Country Status (13)

Country Link
US (2) US4110351A (enExample)
JP (1) JPS5844668B2 (enExample)
AU (1) AU473143B2 (enExample)
BE (1) BE813040A (enExample)
CA (1) CA1077051A (enExample)
CH (1) CH593960A5 (enExample)
DE (1) DE2414680C2 (enExample)
FR (1) FR2223030B1 (enExample)
GB (1) GB1413648A (enExample)
NL (1) NL178967C (enExample)
PH (1) PH17946A (enExample)
SE (1) SE417512B (enExample)
ZA (1) ZA741420B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017514A (en) * 1975-06-16 1977-04-12 Richardson-Merrell Inc. Hypolipidemic agents
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
JPS621279U (enExample) * 1985-06-17 1987-01-07
US4980371A (en) * 1988-12-21 1990-12-25 Merrell Dow Pharmaceuticals Antiretroviral furan ketones
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5665874A (en) * 1989-01-17 1997-09-09 John Hopkins University Cancer related antigen
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
US7576131B2 (en) * 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US6262118B1 (en) 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US6624194B1 (en) * 1999-06-04 2003-09-23 Metabolex, Inc. Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
US20060014785A1 (en) * 2004-05-25 2006-01-19 Metabolex, Inc. Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
WO2005115383A2 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Substituted triazoles as modulators of ppar and methods of their preparation
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
CA2668414C (en) * 2006-11-03 2015-02-10 Qlt Inc. Methods of treating dermatological disorders or conditions
AU2013203113B2 (en) * 2009-07-08 2015-03-26 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
WO2011005660A1 (en) 2009-07-08 2011-01-13 Valocor Therapeutics, Inc. Tofa analogs useful in treating dermatological disorders or conditions
HK1243708A1 (zh) 2015-02-05 2018-07-20 Dermira, Inc. 用於制备2-糠酸衍生物的合成方法
WO2019072478A1 (en) 2017-10-10 2019-04-18 Galderma Research & Development SPECIFIC ACETYL-COA CARBOXYLASE INHIBITORS FOR USE IN THE TREATMENT AND / OR PREVENTION OF ACNE
WO2024026012A1 (en) * 2022-07-29 2024-02-01 The Regents Of The University Of California Compositions and methods for treating metabolic disorders
WO2025165758A1 (en) * 2024-01-31 2025-08-07 The Regents Of The University Of California Combination formulations and methods for treating severe metabolic disorders or diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517050A (en) * 1966-10-03 1970-06-23 Merck & Co Inc Ester and amide derivative of (3-trifluoromethylphenoxy) (4 - halophenyl)acetic acid
US3716644A (en) * 1971-07-15 1973-02-13 American Cyanamid Co Hypolipidemic agents

Also Published As

Publication number Publication date
DE2414680C2 (de) 1983-12-22
NL178967C (nl) 1986-06-16
NL7404425A (enExample) 1974-10-04
JPS49127963A (enExample) 1974-12-07
CA1077051A (en) 1980-05-06
PH17946A (en) 1985-02-11
BE813040A (fr) 1974-07-15
JPS5844668B2 (ja) 1983-10-04
SE417512B (sv) 1981-03-23
AU6640974A (en) 1975-09-11
DE2414680A1 (de) 1974-10-17
FR2223030B1 (enExample) 1977-05-06
CH593960A5 (enExample) 1977-12-30
FR2223030A1 (enExample) 1974-10-25
NL178967B (nl) 1986-01-16
AU473143B2 (en) 1976-06-17
US4110351A (en) 1978-08-29
GB1413648A (en) 1975-11-12
US4146623A (en) 1979-03-27

Similar Documents

Publication Publication Date Title
JPS5110188A (en) Suiseinoyoeki mataha bunsanekinoshohoyososeibutsu
JPS51102895A (en) Suieiyomizuhire
ZA741420B (en) Hypolipidemic agents
PH9722A (en) 1-aryloxy-2-hydroxy-3-alkynylamino-propanes
ZA742836B (en) Railbed
CY1043A (en) Alpha-aminoacal-3-halo-cephalosporins
PH11030A (en) New pregnane-21-acid-derivatives
ZA741421B (en) Hypolipidemic agents
ZA746133B (en) New d-homo-steroids
JPS5133113A (en) Garasuitano kanetsushoryokanetsuro
ZA741623B (en) Alfa-alkylbenzyl lactamimides
IL45790A0 (en) 7-methoxycephalosporins
ZA747728B (en) Hypolipidemic alkensulfonamides
AU7351374A (en) Carbo-chlorination
ZA746132B (en) New d-homo-steroids
ZA743077B (en) Phenyl-thiadiazolyl-thiourea
PH10428A (en) 17beta-hydroxy-16-dimethlester-4-en-3-one
JPS51102615A (en) Fudojikisutoritsupu hetsudo
AU6797274A (en) Dichlorothiazolylureas
AU6598974A (en) 6-amino-th-benzocyclohepten-7-ones
JPS5154727A (en) Koryukudohodengatagazohyojisochi
IL44428A0 (en) New thiadiazolylimidazolidinones
ZA741626B (en) New thiadiazolylimidazolidinones
PH10098A (en) Alkylsulfobenzyl penicillines
JPS5730827A (en) Cinerama